ArticleFrontiers in neurology2023

Real-world efficacy and tolerability of fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, observational study.

Christopher Kjaer Cullum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.